共 192 条
[1]
Arnold M(2015)Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory Eur J Cancer 51 1164-1187
[2]
Karim-Kos HE(2003)Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients Br J Cancer 88 1721-1726
[3]
Coebergh JW(2014)VE-cadherin at a glance Cell Tissue Res 355 515-522
[4]
Byrnes G(2011)RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer J Clin Oncol 29 4286-4293
[5]
Antilla A(2004)X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252-7259
[6]
Ferlay J(2003)Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor Cancer 97 545-553
[7]
Renehan AG(2010)Survival differences among women with de novo stage IV and relapsed breast cancer Ann Oncol 21 2169-2174
[8]
Forman D(2013)Endothelial adherens junctions at a glance J Cell Sci 126 2545-2549
[9]
Soerjomataram I(2013)Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 1374-1403
[10]
Bachelot T(2016)Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion Br J Cancer 114 1019-1026